• End date
    Jul 26, 2022
  • participants needed
  • sponsor
    University of Massachusetts, Worcester
Updated on 26 January 2021
venous thromboembolism


Given the risks associated with direct oral anticoagulants (DOAC)s and the lack of defined pathways for patients prescribed this class of medications, the study intervention has the potential for enormous impact in preventing medication errors and improving the quality of care transition, patient knowledge, and adherence with DOAC therapy.


Patients first treated with direct oral anticoagulants (DOACs) in an ambulatory setting are at an elevated risk for adverse drug events (ADEs) or potential ADEs from medication errors. An intervention that integrates clinical pharmacists, a pharmacy technician, and follows a checklist published by experts at the Anticoagulation Forum can prevent adverse outcomes. The Investigators propose research on the effectiveness, implementation, and dissemination for a care transition intervention that follows the checklist which includes evaluation for appropriateness of DOAC use, assistance with drug procurement, telephone access to an anticoagulation expert, and other best practice recommendations.

Condition Arrhythmia, Hemorrhage, Atrial Fibrillation, Venous Thromboembolism, Cerebrovascular accident, Cardiovascular Disease, Thromboembolism, Atrial Fibrillation (Pediatric), Stroke, Dysrhythmia, cardiovascular diseases, cardiovascular disease (cvd), cardiovascular system diseases, cardiovascular disorders, cerebrovascular accidents, strokes, cerebral
Treatment Clinical Pharmacist Intervention
Clinical Study IdentifierNCT04068727
SponsorUniversity of Massachusetts, Worcester
Last Modified on26 January 2021


Yes No Not Sure

Inclusion Criteria

Is your age greater than or equal to 18 yrs?
Gender: Male or Female
Do you have any of these conditions: Cerebrovascular accident or Arrhythmia or Venous Thromboembolism or Hemorrhage or Thromboembolism or Dysrhythmia or Atrial Fibrillation or Stroke or C...?
Do you have any of these conditions: Cerebrovascular accident or cardiovascular diseases or cardiovascular disease (cvd) or Dysrhythmia or Hemorrhage or cardiovascular system diseases or ...?
Age 18
New prescription of DOAC within 4 days of consent OR continued DOAC use for a patient with new episode of worsening thromboembolic or bleeding event within 4 days of consent or discharged from the hospital with DOAC prescription within 4 days of consent
Fluency in English, Portuguese, or Spanish

Exclusion Criteria

Currently hospitalized with inpatient status (as opposed to observation status)
Age < 18
Pregnant patients (medications are contraindicated)
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Phone Email

Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note